Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Audit Report / Information 2015

Mar 18, 2016

3662_rns_2016-03-18_b0fd081c-d162-4831-943a-ef5b1716bf5e.html

Audit Report / Information

Open in viewer

Opens in your device viewer

Financial statements for Medistim ASA for 2015

Financial statements for Medistim ASA for 2015

The Board of Medistim ASA has approved the Annual

Accounts for 2015. The Annual Accounts are without

changes from the preliminary Annual Accounts published

on the 29th of February 2016. The Annual General

Meeting will be held on 19th of April 2016, and the

share will be listed ex dividend NOK 1.65 per share on

the 20th of April 2016.

The Annual Report for 2015 will be published on the

company's website and notified to the Oslo Stock

Exchange in April 2016.

About Medistim

Medistim was established in 1984, and has a track

record of profitable growth over the past >10 years.

The company is a pioneer within its segment, and

continues to invest in new product development.

Medistim has wholly owned subsidiaries with sales

organizations in the US, Germany, Denmark, UK and

Norway, in addition to the around 50 distributors in

Europe, Asia, Middle East, Africa and South America.

For more information, visit the Medistim home page:

www.Medistim.com